Jennifer Isler Ocain

Jennifer Isler OCain, PhD has an extensive work experience in the pharmaceutical industry. Jennifer started their career at Wyeth in 2005 as Laboratory Head, Genomic Biomarkers, where they worked until 2008. Jennifer then joined Boehringer Ingelheim as Head, Biotherapeutic Bioanalysis and worked there until 2014. After that, Jennifer joined Pfizer and held various roles including Director, Competitive Intelligence from 2014 to 2019, and Director, Strategy & Consulting from 2019 to 2020. Currently, they are working as the Executive Director, Portfolio Strategy & Alliance Management at Catalyst Pharmaceuticals, Inc. from 2022 onwards.

Jennifer Isler OCain, PhD obtained their Doctor of Philosophy degree in Cell/Cellular and Molecular Biology from the University of Pennsylvania, where they studied from 1996 to 2001.